Article
Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementation.
Molecular therapy : the journal of the American Society of Gene Therapy - 3 Dec 2025
Zhang Ziqi, Liang Qian, Xu Xiaoqian, Li Yang, Chen Changming, Ding Qiulan, Zhou Aiwu, Wu Wenman, Wang Xuefeng, Dai Jing
Abstract excerpt
Gene therapy remains the only cure for von Willebrand disease (VWD), but it is limited by the large von Willebrand factor (VWF) gene size. Variants affecting the VWF propeptide (VWFpp) impair multimerization, causing type 2A/IIC VWD. VWFpp serves as a pH-sensitive template for VWF multimer assembly, suggesting that in trans VWFpp supplementation may restore multimerization in VWF variants with defective...
Topics
- von Willebrand Factor
- Animals
- Humans
- Mice
- von Willebrand Disease, Type 2
- Protein Multimerization
- Disease Models, Animal
- Mice, Transgenic
- Mutation
- Genetic Therapy
